News

  • Abstract Submission Open for AUS 2016 Spring Meeting

    2016-03-18 15:42 | Russell Read (Administrator)

  • American Uveitis Society Spring Meeting to be held in conjunction with ARVO Annual Meeting

    2016-03-18 14:45 | Russell Read (Administrator)

    The American Uveitis Society today announced that its annual Spring meeting will be held in Seattle WA in conjunction with the annual meeting of the Association for Research in Vision and Ophthalmology. Further details can be found in the Events section of the Society's website, www.UveitisSociety.org.

  • Justine Smith MD PhD Recognized for Participation in the Council of the American Academy of Ophthalmology

    2015-11-15 19:57 | Russell Read (Administrator)

    Justine Smith MD PhD was recognized for participation on the Council of the American Academy of Ophthalmology during AAO 2015 in Las Vegas.  Dr. Smith served for 6 years as a councilor for the American Uveitis Society.

    The Council serves as an advisory body to the Academy’s Board of Trustees.  More than 100 Academy members serve on this body and act as liaisons between their society and the Academy bringing issues identified by their societies to the attention of the Academy’s Board of Trustees. Issues are brought to the Academy Board of Trustees as Council Advisory Recommendations (CARs).  Each spring the Council meets to debate and formulate its recommendations for the Academy Board.

    Representatives to the Council are elected by each state society and by subspecialty societies and specialized interest groups in ophthalmology.  On December 31st, Dr. Smith will conclude her term on the Academy Council. Russell Read MD PhD has been elected by the American Uveitis Society to serve as Councilor to the Academy and will begin his term on January 1, 2016 and participate at the Spring Council Meeting in conjunction with the April 13-16, 2016 Mid-Year Forum in Washington, D.C.    

  • American Uveitis Society Fall Meeting to be held in conjunction with AAO Annual Meeting

    2015-09-04 15:48 | Russell Read (Administrator)

    The American Uveitis Society announces that its Fall Meeting will be held in conjunction with the AAO Annual Meeting in Las Vegas, NV on October 15, 2015 at Treasure Island.  Members and guests are invited to join the AUS for a social hour from 7 to 8 PM with the scientific meeting to follow immediately at 8 PM.

    AUS members who's dues are current may attend the meeting at no charge. A guest fee of $50 is accessed for others, but is  waived for non-AUS members who are the presenter of a free paper.

    Dr. Emmett Cunningham will moderate “Controversies in Uveitis.  Case-based comments from a non-consensus panel of experts", followed by a free paper session. The program committee invites abstracts presenting research that will not be presented at the AAO meeting.  Case presentations will be considered if they are of sufficient interest.  Please only submit one abstract per first author.  

    Abstract submission will be electronic and the submission site is now open. Submissions will close on September 30, 2015. Decisions will be made by October 9, 2015 and the corresponding author notified via email.  

    Sincerely,

    Nisha Acharya, M.D., M.S.

    nisha.acharya@ucsf.edu

    Program Chair, AUS Fall Meeting


    Russell W. Read, MD, PhD

    rwread@gmail.com

    Executive Secretary

    American Uveitis Society

     

  • AUS Co-Sponsors First-Ever Congressional Briefing on Uveitis

    2015-06-15 20:28 | Russell Read (Administrator)
    The American Uveitis Society joined the Alliance for Eye and Vision Research (AEVR) and other societies and patient advocacy groups to co-sponsor the first ever Congressional Briefing on Uveitis. AUS member Gary N. Holland, MD, Professor of Ophthalmology at the David Geffen School of Medicine at UCLA and Jack H. Skirball Chair in Ocular Inflammatory Diseases, was a featured speaker.

    Left to right: Gary N Holland MD (Jules Stein Eye Institute, David Geffen School of Medicine at UCLA), Janine Austin Clayton MD (National Institutes of Health Associate Director for Research on Women’s Health), and James Jorkasky ( Executive Director of AEVR/NAEVR).

     Full details of the briefing can be found on the AEVR website.

  • 13th Congress of the International Ocular Inflammation Society to be held in US for first time

    2015-05-09 07:43 | Russell Read (Administrator)

    The 13th Congress of the International Ocular Inflammation Society will be held in San Francisco from September 25 to 27, 2015. This will be the first IOIS Congress to be held in the US. More than 25 societies focused on ocular inflammation will host sessions during the three day meeting along with IOIS Sections focused on all aspects of ocular immunology and disease. Further details can be found at the Congress website.

  • AUS member Steven Yeh Featured in NPR story on Ebola survivor's battle with Uveitis

    2015-05-08 20:03 | Russell Read (Administrator)


  • NEI/FDA Endpoints Workshop on Ocular Inflammatory Diseases

    2015-03-22 15:44 | Russell Read (Administrator)

    The National Eye Institute (NEI and US Food and Drug Administration (FDA) are holding a public Workshop on Endpoints for Ocular Inflammatory Diseases on the campus of the NIH on March 26, 2015 in the Masur Auditorium.

    Details regarding the meeting can be found here:

    2015 NEI/FDA Endpoints Workshop


  • MUST Research Group Seeks New Sites

    2015-02-03 12:00 | Russell Read (Administrator)

    The MUST Research Group, which successfully completed the Multicenter Uveitis Steroid Treatment (MUST) Trial is conducting two new trials, the Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial and the Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy (MERIT) Trial. Both are funded by the National Eye Institute. POINT will compare the relative efficacy of three common approaches for the regional treatment of uveitic macular edema, periocular and intravitreal triamcinolone acetonide, and the dexamethasone intravitreal implant. MERIT will evaluate the relative efficacy of intravitreal ranibizumab and intravitreal methotrexate and the dexamethasone intravitreal implant for the treatment of uveitic macular edema persisting after intravitreal triamcinolone acetonide. The POINT Trial will be initiated in Spring 2015 in clinical centers that are currently following participants in the MUST Trial Follow-up Study and to have new clinical centers selected and preparing for start-up by the time of our Research Group meeting in June 2015. The MERIT Trial will begin approximately 12 months after the start of POINT; the trials will run concurrently until POINT is completed.

    Those interested in being a clinical center for POINT and MERIT should visit the Clinic Applications site or read the attached document to learn more.

  • FOCIS Abstract Submission Closes Jan 28

    2015-01-21 15:56 | Russell Read (Administrator)

    Abstract submission for FOCIS 2015 closes Wednesday, January 15. 

    The American Uveitis Society is a member society of FOCIS, the Federation of Clinical Immunology Societies.

700 18th Street South Suite 601
Birmingham Alabama 35233 USA

Copyright © The American Uveitis Society. All rights reserved.

The American Uveitis Society is a 501(c)6 non-profit organization

Legal Disclaimer  |  Site Map

Powered by Wild Apricot Membership Software